Azithromycin in cystic fibrosis (multiple letters) [1]

European Respiratory Journal

Volumn 25, Issue 4, 2005, Pages 771-772

  Kastelik, J A ^a   Peckham, D G ^a   Conway, S ^a   Southern, K W ^b   Barker, P M ^c  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; CLINICAL TRIAL; CYSTIC FIBROSIS; DISEASE EXACERBATION; DRUG CHOICE; DRUG RESPONSE; DRUG USE; GRAM NEGATIVE INFECTION; HUMAN; LETTER; LONG TERM CARE; LUNG FUNCTION; MEDICAL AUDIT; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT DISEASE;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CYSTIC FIBROSIS; HUMANS; MALE; PSEUDOMONAS INFECTIONS;

EID: 17244380808     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00129304     Document Type: Letter

References (0)